Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Contrafect (CFRX)

Contrafect (CFRX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0500 -0.0194 (-27.95%) 12/05/23 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0500 unch (unch) -
Quote Overview for Tue, Dec 5th, 2023
Day Low
0.0457
Day High
0.0620
Open 0.0590
Previous Close 0.0694 0.0694
Volume 910,200 910,200
Avg Vol 234,420 234,420
Stochastic %K 27.27% 27.27%
Weighted Alpha -97.52 -97.52
5-Day Change -0.0077 (-13.34%) -0.0077 (-13.34%)
52-Week Range 0.0430 - 13.0160 0.0430 - 13.0160
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 535
  • Shares Outstanding, K 10,705
  • Annual Sales, $ 0 K
  • Annual Income, $ -65,150 K
  • EBIT $ -30 M
  • EBITDA $ -29 M
  • 60-Month Beta 0.29
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -19.27
  • Most Recent Earnings $-0.50 on 11/14/23
  • Next Earnings Date 11/13/23
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0430 +16.28%
on 11/13/23
Period Open: 0.2569
0.2755 -81.85%
on 11/06/23
-0.2069 (-80.54%)
since 11/03/23
3-Month
0.0430 +16.28%
on 11/13/23
Period Open: 0.7777
1.0400 -95.19%
on 09/07/23
-0.7277 (-93.57%)
since 09/05/23
52-Week
0.0430 +16.28%
on 11/13/23
Period Open: 11.4400
13.0160 -99.62%
on 12/06/22
-11.3900 (-99.56%)
since 12/05/22

Most Recent Stories

More News
ContraFect: Q3 Earnings Snapshot

ContraFect: Q3 Earnings Snapshot

CFRX : 0.0500 (-27.95%)
ContraFect: Q2 Earnings Snapshot

ContraFect: Q2 Earnings Snapshot

CFRX : 0.0500 (-27.95%)
ContraFect: Q1 Earnings Snapshot

ContraFect: Q1 Earnings Snapshot

CFRX : 0.0500 (-27.95%)
ContraFect: Q4 Earnings Snapshot

ContraFect: Q4 Earnings Snapshot

CFRX : 0.0500 (-27.95%)
ContraFect Announces Independent DSMB Recommends Exebacase Phase 3 DISRUPT Study Be Stopped for Futility Following Interim Analysis

YONKERS, N.Y., July 13, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a biotechnology company focused on the discovery and development...

CFRX : 0.0500 (-27.95%)
Presentations at ASM Microbe Conference Demonstrate Potential of ContraFect’s Direct Lytic Agents (DLAs) to Address MRSA Infections

YONKERS, N.Y., June 14, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...

CFRX : 0.0500 (-27.95%)
ContraFect to Present Data Demonstrating the Potential of Its Direct Lytic Agents (DLAs) to Combat MRSA at ASM Microbe 2022

YONKERS, N.Y., June 06, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage biotechnology company focused on the...

CFRX : 0.0500 (-27.95%)
ContraFect Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

YONKERS, N.Y., May 20, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX) (ContraFect), a late clinical-stage biotechnology company focused...

CFRX : 0.0500 (-27.95%)
ContraFect Reports First Quarter 2022 Financial Results and Provides Business Update

Phase 3 DISRUPT study achieves enrollment of MRSA patients necessary for DSMB to conduct interim futility analysis...

CFRX : 0.0500 (-27.95%)
Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV

LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's...

VMAR : 5.2400 (+9.07%)
NSCI.VN : 0.280 (-5.08%)
RCAT : 5.88 (-0.17%)
DDDX : 0.0156 (+4.00%)
NXGL : 2.98 (+3.47%)
NFLD.CN : 0.0300 (-14.29%)
MMMB : 3.75 (+1.08%)
PETV : 0.5997 (+0.96%)
NMRD : 0.0002 (unch)
DUOT : 5.64 (+6.21%)
AAT.VN : 0.015 (unch)
BUD.VN : 0.310 (+5.08%)

Business Summary

ContraFect Corporation is a biotechnology company. The Company is focused on protein and antibody therapeutic products for life-threatening infectious diseases. Its product candidates are CF-301, a lysin for the treatment of Staph aureus bacteremia, and CF-404, a combination of mAbs for the treatment...

See More

Key Turning Points

3rd Resistance Point 0.0757
2nd Resistance Point 0.0689
1st Resistance Point 0.0594
Last Price 0.0500
1st Support Level 0.0431
2nd Support Level 0.0363
3rd Support Level 0.0268

See More

52-Week High 13.0160
Fibonacci 61.8% 8.0603
Fibonacci 50% 6.5295
Fibonacci 38.2% 4.9987
Last Price 0.0500
52-Week Low 0.0430

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies